|
| 37646670 | Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT study. | Haematologica | 2024 |
| 36208727 | Transfer of Extended Spectrum Cephalosporin Resistant Enterobacteriaceae Among Patients on an HSCT Unit and the Value of Surveillance and Contact Isolation. | Transplant Cell Ther | 2023 |
| 35644294 | Extended spectrum cephalosporin resistant enterobacteriaceae carriage and infection in patients admitted with newly-diagnosed acute leukemia. | Am J Infect Control | 2023 |
| 37086852 | An Algorithm Addressing the Problem of Overdiagnosis of Clostridioides difficile Infections in Hematopoietic Stem Cell Transplantation Recipients: Effects on C. difficile Infection Rates and Patient Outcomes. | Transplant Cell Ther | 2023 |
| 35227310 | Successful administration of chimeric antigen receptor (CAR) T-cell therapy in patients requiring hemodialysis. | Exp Hematol Oncol | 2022 |
| 35583358 | Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma. | Future Oncol | 2022 |
| 35839786 | Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study. | Lancet Oncol | 2022 |
| 35493119 | Ibrutinib for Hospitalized Adults With Severe Coronavirus Disease 2019 Infection: Results of the Randomized, Double-Blind, Placebo-Controlled iNSPIRE Study. | Open Forum Infect Dis | 2022 |
| 35780813 | Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial. | Chest | 2022 |
| 33688640 | Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. | Res Sq | 2021 |
| 33743799 | Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. | Trials | 2021 |
| 32196881 | Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients? | Transpl Infect Dis | 2020 |
| 31751470 | Antimicrobial Stewardship in a Hematological Malignancy Unit: Carbapenem Reduction and Decreased Vancomycin-Resistant Enterococcus Infection. | Clin Infect Dis | 2020 |
| 33015645 | Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. | Lancet Rheumatol | 2020 |
| 30471971 | Clostridioides difficile colonization and infection in patients with newly diagnosed acute leukemia: Incidence, risk factors, and patient outcomes. | Am J Infect Control | 2019 |
| 31532030 | Clostridioides difficile colonization and infection in patients admitted for a first autologous transplantation: Incidence, risk factors, and patient outcomes. | Clin Transplant | 2019 |
| 31177566 | Amlodipine and calcineurin inhibitor-induced nephrotoxicity following allogeneic hematopoietic stem cell transplant. | Clin Transplant | 2019 |
| 31425923 | Chronic myelomonocytic leukemia with ETV6-ABL1 rearrangement and SMC1A mutation. | Cancer Genet | 2019 |
| 31046849 | Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia. | Infect Control Hosp Epidemiol | 2019 |
| 29975816 | The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation. | Transpl Infect Dis | 2018 |
| 27890428 | Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes. | Biol Blood Marrow Transplant | 2017 |
| 28369204 | Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation. | Clin Infect Dis | 2017 |
| 27214585 | Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients. | Transpl Infect Dis | 2016 |
| 27287734 | Room contamination, patient colonization pressure, and the risk of vancomycin-resistant Enterococcus colonization on a unit dedicated to the treatment of hematologic malignancies and hematopoietic stem cell transplantation. | Am J Infect Control | 2016 |
| 19966849 | Sirolimus for treatment of steroid-refractory acute graft-versus-host disease. | Bone Marrow Transplant | 2010 |
| 19337429 | Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab. | Ther Clin Risk Manag | 2008 |
| 15641035 | Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's 20-year experience. | Cancer | 2005 |
| 12968972 | Hot flashes in breast cancer survivors. | Breast J | 2003 |